Context: In recent years there has been an increase in the availability of 'novel psychoactive substances (NPS)' or 'legal highs'. In turn, there is concern as to the risks these compounds pose as compared to those posed by traditionally misused substances such as illicit diamorphine (heroin), methadone, cocaine, and amfetamines. Methods: We reviewed deaths where opiates/opioids, stimulants, hypnosedatives, hallucinogens, or volatile substances were mentioned on the death certificate in England and Wales, 1993-2016 as recorded on the Office for National Statistics drug poisoning deaths database. Deaths were analysed by year of registration of death, age, sex, intent, drug(s) involved, and the presence of alcohol (ethanol). Results: There were 68,347 drug-related deaths in England and Wales (includes both licit and illicit substances), of which 15,457 were either coded as, or had mention of, drug dependent/non-dependent substance abuse on the death certificate. Opioids, particularly diamorphine/morphine and methadone, featured in most deaths. Diamorphine/morphinerelated deaths (17,402) increased from 155 in 1993 to 981 in 2001, and then remained relatively stable
Introduction
Unintentional substance misuse-related fatal poisoning is a worldwide problem, but defining and gathering data on substance misuse-related poisoning deaths is not straightforward (Martins et al., 2015; Public Health England (PHE), 2016; Trinidad et al., 2016; Warner et al., 2016) . In the study of substance misuse, the term 'drug' usually refers to compounds that have known abuse potential (e.g. diamorphine, methadone, amfetamines, cocaine, etc.). However, many such compounds have legitimate uses and simply counting deaths in which a substance features may risk overestimating deaths relating to misuse of that substance, especially when, as is often the case, more than one compound has been ingested. Moreover, some substances, cannabis for example, have minimal acute toxicity and 'misuse' may include use of drugs or substances such as balloon gas (helium) to facilitate suicide.
In England and Wales a number of definitions based on International Classification of Diseases (ICD) codes have been used to enumerate drug-related and substance misuse-related deaths. The Office for National Statistics (ONS) have a 'standard' definition for defining drug-related deaths that includes all poisoning deaths when the underlying cause of death was coded as (i) accidental poisoning by drugs, medicaments and biological substances (ICD-9: E850-E858, ICD-10: X40-X44), (ii) assault by drugs, medicaments and biological substances (ICD-9: E962.0, ICD-10: X85), (iii) mental and behavioural disorders due to drug useexcluding alcohol and tobacco 304, , ICD-10: F11-F16, F18-F19), (iv) intentional self-poisoning by drugs, medicaments and biological substances (ICD-9: E950.0-E950.5, ICD-10: X60-X64), or (v) poisoning by drugs, medicaments and biological substances of undetermined intent (ICD-9: E980.0-E980.5, ICD-10: Y10-Y14). This definition is broad, and includes not only drugs that are used for medicinal purposes, e.g. paracetamol (acetaminophen), but also those that have no legitimate use in the UK such as metamfetamine. This definition, however, does not include some substances, for example liquefied petroleum gas ('butane'), that do not have a medicinal use, but are widely misused. Other poisons such as carbon monoxide and hydrogen sulfide that are widely misused to facilitate suicide are also excluded.
The ONS also has a 'drug misuse' definition that is somewhat narrower than the ONS Standard definition and not only includes deaths where a drug controlled under the Misuse of Drugs Act 1971 as amended, but also include compounds listed under a Temporary Class Drug Order, and when the underlying cause of death was coded as (i) accidental poisoning, (ii) intentional self-poisoning, (iii) poisoning with undetermined intent, (iv) assault with a drug, medicament or biological substance, or (v) where the deceased had a mental or behavioural disorder associated with volatile substance use F18) . Also included in the ONS drug misuse definition are those deaths where the cause of death was attributed to psychoactive substance use F19) . Data extracted using the 'drug misuse' definition are not revised as new compounds are added to the Misuse of Drugs Act, except for tramadol where after discussion with experts it was agreed that it was best to revise the series.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has a definition for drug misuse-related deaths for use when data are extracted from general mortality registers, also known as 'Selection B'. This definition includes deaths where the underlying cause was coded as (i) mental and behavioural disorders due to psychoactive substance use 292, 304.0, 305.9, F19) , and (ii) poisonings that are accidental (ICD-9; E850.0, E850.8, E854.1-2, E855.2, E858.8, ICD-10; X41-42); intentional (ICD-9; E950.0, E950.4, ICD-10; X61, X62), or of undetermined intent (E980.0, E980.4, ICD-10; Y11, Y12), where opiates, cocaine, amfetamines and derivatives, cannabis, and hallucinogens are also mentioned (ICD-9; N965.0, N968.5, N969.6, N969.7, ICD-10; T40.0-9, T43.6) (EMCDDA, 2007) . Additionally, there is a further EMCDDA definition for use when extracting data from special mortality registers, such as that maintained by the National Programme on Substance Abuse Deaths (Corkery, 2008) .
A further complication when interpreting fatal poisoning data, and in particular substance abuse-related deaths, is the introduction of ICD revisions. Broadly, ICD codes are comparable between revisions, but there can be significant differences. From 2001 to end-2010 ICD-10 v2001 was used for coding deaths in England and Wales, however in 2011, ICD-10 v2010 was introduced. The main change in this new version involved the rules used in selecting the underlying cause of death from the death certificate. In ICD-10 v2001, if both accidental poisoning and drug dependence were mentioned on the death certificate, the underlying cause of death would be coded as mental and behavioural disorders due to drug use (ICD-10; F11-F16, F18-F19). However, in ICD-10 v2010, these deaths would most likely be coded as accidental poisoning from drugs (ICD-10: X40-X44) (ONS, 2012; PHE, 2013) . A consequence has been better appreciation of the role of acute ethanol poisoning in causing death (Handley and Flanagan, 2014) .
In the USA, an approach using National Vital Statistics System mortality files linked to electronic files containing literal text information from death certificates has been used to gather information on drug overdose deaths, 2010-2014. Drug overdose was defined using ICD-10 underlying cause-of-death codes X40-X44 (unintentional), X60-X64 (intentional), X85 (homicide), and Y10-Y14 (undetermined intent). Amongst deaths with an underlying cause of death of drug overdose, the literal text in three fields of the death certificate (i.e. the cause of death from Part I, significant conditions contributing to death from Part II, and a description of how the injury occurred from Box 43) were searched to identify drug mentions Warner et al., 2016) . This and similar approaches have been used to gather data on trends in not only drug overdose deaths (Hedegaard et al., 2017) , but also opioid-related deaths (Chen et al., 2014; Hedegaard et al., 2015; Jones et al., 2016; Rudd et al., 2016) .
Methods
We searched the ONS drug poisoning deaths database (ONS, 2016) for data on fatal poisoning, England and Wales, 1993-2016 inclusive. Deaths registered include those of non-residents, and those deaths that may have occurred outside England or Wales but have been recorded in these latter countries. Deaths were analysed by year of registration of death, age, sex, intent, country where death occurred, drug(s) involved, and the presence of alcohol (ethanol) . Note that a 'mention' of alcohol (ethanol) in such cases may not be supported by toxicological analysis since the presence of empty alcohol bottles where the body was found, or evidence of long-term alcohol abuse (e.g. cirrhosis of the liver), might be recorded as 'alcohol present at time of death'. Mid-year population estimates for England and Wales, 1993-2016 were obtained from the ONS (ONS, 2017).
Results

Poisoning overview -Long-term trends
Over the period studied there were 68,347 (68 % male) drug-related deaths (ONS standard definition, includes both licit and illicit drugs) in England and Wales. Deaths increased year-on-year from 2,178 (1993) to 3,110 (1999) , after which deaths remained relatively constant (some 2,786 per year) until 2012 (2, 597) , where upon deaths increased to 3,744 in 2016. Using either the ONS drug misuse definition, or the EMCDDA definition of a drug abuse-related death to extract data give very similar figures and trends over this period, the numbers of deaths recorded being approximately half of those recorded using the ONS standard definition (Table 1) .
Dependent/non-dependent abuse. Poisoning deaths where the underlying cause of death was coded as dependent/ non-dependent drug abuse 304, , or where these codes were mentioned on the death certificate, but another underlying cause of death such as accidental poisoning was chosen comprised 23% (15,457) of all drug-related deaths (standard ONS definition) in England and Wales, 1993-2016 . Most (84 %) of these deaths were in males.
Annual numbers of deaths recorded as dependent/nondependent abuse increased from 277 (1993) to 809 (1999) , and after remaining relatively stable until 2010 (some 800 per annum), have since declined (Table 1) . There were few such deaths where the underlying cause of death was recorded as either intentional self-poisoning, which includes 'undetermined intent', i.e. it was not clear whether the intent was to self-harm or not (187), or assault (6).
The effect of the introduction of ICD-10 v2010 on coding the underlying cause of death as dependent/ non-dependent drug abuse is evident if the appropriate codes (ICD-10: F11-F16, F18-F19) alone are used to extract deaths. Such deaths fell from 600 (2010) to 103 (2011) whereas deaths coded to accidental poisoning 1,166 (81) 935 (86) 505 (85)(ICD-10; X40-X44) increased (1,268 in 2010, 1,552 in 2011) . The increasing use of narrative verdicts by coroners with a corresponding decrease in use of some ICD codes may have also had an impact (Gunnell et al., 2011) . As to the compounds involved in dependent/ non-dependent drug abuse-related deaths, the five compounds most commonly recorded were: diamorphine (heroin)/morphine, methadone, cocaine, diazepam, and amfetamine. However, general terms such as 'opiate', 'volatile substance abuse' (VSA), and 'benzodiazepine' were also commonly recorded ( Table 2) . These findings are broadly in keeping with other European countries, especially those in the Nordic region (Denmark, Finland, Norway, Sweden, Iceland) , where fatal poisoning in substance abusers is primarily from diamorphine/morphine, and methadone, except for Finland where there are relatively few diamorphine/morphine-related deaths (2012: 3) as compared to buprenorphine-related deaths (2012: 42) (Simonsen et al., 2015 Figure 1 ). Most (median 86, range 74-88%) such deaths were of males. The male:female ratio in diamorphine/morphine-related deaths remained relatively constant (median, range: 5.9, 2.9-7.4) during the period studied. Note that these are mentions of diamorphine/morphine on death certificates, only some 30% of such deaths were actually coded as being due to heroin.
Deaths per million population ( Figure 2 ) show a similar trend to the annual number of deaths, and although increasing in recent years are still considerably lower than in Scotland (2016: males 131.3, females 46.1 diamorphine/morphine deaths per million population) (National Records of Scotland, 2016).
Co-ingested compounds. With regards to co-ingested compounds, 35% (6,162) of diamorphine/morphine-related deaths had another drug (with or without alcohol) recorded on the death certificate. Methadone, diazepam, and cocaine were the most frequently co-ingested drugs (1,754, 1,541, and 1,336, respectively) . The general term 'benzodiazepine' was also recorded on 407 instances. The proportion of deaths where diamorphine/morphine was mentioned alone, with or without alcohol, remained relatively stable, 1993-2000 (median 75, range 69-78%), but has since (2016) declined to 49%. The proportion of diamorphine/morphine deaths that also involved methadone ranged from 6% to 15% (average 10%, Table 3 ). Of co-ingested drugs, methadone and other opioids and indeed alcohol are the compounds most likely to enhance the toxicity of diamorphine/morphine, and vice versa. The combination of opioids with gabapentin or pregabalin may also increase the risk of death through either reversal of opioid tolerance, or an additive effect of the drugs to depress respiration (Lyndon et. al., 2017) . 755 (76) 336 (53) 66 2000 851 (78) 269 (56) 59 2001 981 (74) 244 (52) 54 2002 865 (72) 199 (46) 56 2003 696 (69) 201 (37) 58 2004 751 (66) 219 (48) 44 2005 842 (67) 220 (45) 55 2006 713 (70) 241 (52) 55 2007 829 (71) 325 (51) 78 2008 897 (65) 378 (51) 80 2009 880 (64) 408 (45) 91 2010 791 (62) 355 (49 Of the 326 (2%) diamorphine/morphine-related deaths in those aged 70 years or more (median, 78, range 70-105 years), most (205, 63%) were alone (without alcohol). Only three of these 326 deaths had drug use/dependence mentioned on the death certificate, and most (211, 65%) were intentional self-poisonings and five were homicides. By way of comparison, of the 17,076 diamorphine/morphine-related deaths in those aged <70 years, 7,476 (44%) were alone (without alcohol), and 7,383 (43%) of all diamorphine/morphinerelated deaths in those aged <70 years had drug use/ dependence mentioned on the death certificate. Co-ingested compounds. Some 48% of methadone-related deaths were attributed to the presence of methadone either alone, or with alcohol, and in some (median, range) 22 (10-40)% each year, diamorphine was recorded on the death certificate in addition to methadone. The proportion of diamorphine/morphine deaths that also involved methadone remained relatively stable over this period (median 10, range 6-15%), as noted above (Table 3) . However, the converse is that the proportion of methadone-related deaths that also feature diamorphine/morphine (median 22, range 10-40%) increased from some 10% (1993-5) to 38% in 2016.
Other compounds ingested in methadone-related deaths were: diazepam (1, 193) , cocaine (447), temazepam (280), dihydrocodeine (249), and amitriptyline (237). In addition, 'benzodiazepine' was mentioned in 334 deaths.
Age at death. As with diamorphine/morphine-related deaths, when methadone-related deaths are studied by age (median 35, range < 1-82 years), the majority (93%) were within the ages 20-59 years. The percentage of methadone-related deaths within the age groups <20 and 20-29 declined steadily from 49% in 1993 to 7% in 2016, whereas those within the age group 40-49 increased (9% in 1993, 41% in 2016) , and those methadone-related deaths between the ages 30 and 39, have remained relatively stable (median 34, range 24-47%) ( Figure 5 ). The number of methadone-related deaths within the age group 20-29, increased from 100 in 1993 to 233 in 1997, where they accounted for 53% of all methadone-related deaths, before rapidly declining to 84 in 2000 (31% of all methadone related deaths), most likely due to the introduction of supervised methadone consumption. By comparison, the 486 methadone-related deaths in 2011 were largely in those aged 30-49 (69%) years.
There were 23 methadone-related deaths in children aged <10 years, 1993-2016, 22 involving methadone alone, by far the highest number of fatal drug poisonings associated with a specific compound in this age group (dosulepin: 10, iron salts: 5, diamorphine/morphine: 4).
Buprenorphine
Buprenorphine is used to treat moderate to severe pain, and may also be used as an alternative to methadone in opiate withdrawal. Over the period studied, there were 166 buprenorphine-related deaths, increasing from three in 2004 to 31 in 2016 (1993-2003, 4 deaths) . Most buprenorphine-related deaths were in males (87%). Buprenorphine is considered to be up to six times safer than methadone with regards to fatal overdose (Marteau et al., 2015) . This is primarily because buprenorphine is a partial opiate agonist/antagonist, hence respiratory depression after buprenorphine use is less likely than with other opioids. Be this as it may there were 41 buprenorphine-related deaths either alone (26), or with alcohol in the period studied. As to other co-mentioned compounds, diazepam was mentioned in 60 deaths, diamorphine/morphine in 41 deaths, and methadone in eight deaths.
Other opioids/opiates
Deaths involving codeine (2, 372) deaths are either when codeine had been co-ingested with other drugs such as paracetamol or other opioids, or had been reported as a metabolite of acetylcodeine, a common constituent of heroin. Deaths where dihydrocodeine was implicated (2, 558) showed a similar trend to those of diamorphine/morphine and methadone in that annual numbers of deaths increased steadily from 69 (1993) to 139 (1999), after which numbers of such deaths remained relatively stable (median 112, range 90-142). Most deaths where codeine or dihydrocodeine were implicated involved other drugs (with or without alcohol, 81% and 62%, respectively). Some 50-60% of mentions of codeine and of dihydrocodeine were in intentional self-poisonings and less than 1% and 13%, respectively, of deaths involving these compounds had dependent/non-dependent drug use mentioned on the death certificate.
In the UK, dihydrocodeine is not licensed for use in the treatment of opiate/opioid dependence, but is sometimes prescribed as an alternative to methadone in opiate detoxification (Robertson et al., 2006) . There have been concerns raised over the increased risk of unintentional fatal overdoses associated with co-administration of dihydrocodeine with buprenorphine, 'street heroin', or methadone (Zamparutti et al., 2011) . In the event, dihydrocodeine was mentioned in only some 2-3% of deaths where diamorphine/morphine (358), methadone (249), or buprenorphine (3) were mentioned.
Deaths from tramadol (1, 899) , having steadily increased from 1 (1996) and approximately half (49%) of all tramadol-related deaths were intentional self-poisonings. Tramadol is considered to have a relatively low abuse potential when compared to other opiates/opioids (e.g. diamorphine/morphine), and this is supported by the fact that dependent/non-dependent drug abuse was only recorded in some 7% of all tramadol-related deaths.
Following the withdrawal of preparations containing both dextropropoxyphene (propoxyphene) and paracetamol (principally co-proxamol) within the UK in 2007, deaths involving this drug declined from some 350 per annum (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) , to being infrequently mentioned (2014: 4, 2015: 7, 2016: 1) . Mentions of either fentanyl (257), or oxycodone (430) on the death certificate have steadily increased from 5 (2007) to 58 (2016) (1999-2006 , some 3 per annum), and from 1 (2001) to 75 (2016), respectively. Increases in deaths from these compounds have also been reported from the US in recent years (Marshall et al., 2017; Warner et al., 2016) . Annual numbers of deaths related to other opioids in England and Wales such as pethidine ((meperidine), 87) and dipipanone (148) have remained stable over the period studied (median (range); 3 (1-8), 6 (1-17) per annum, respectively).
In addition to fentanyl and oxycodone, synthetic opioids are of especial concern as they are also often highly potent and are either added to, or sold as heroin. Therefore, there is a high risk of death with use of these compounds, some of which may be missed on conventional toxicology screening procedures (Pichini et al., 2017; Santacroce et al., 2018; Schneir et al., 2017; Shoff et al., 2017; Swanson et al., 2017) . In 2014, three out of five opioids reported to the EU Early Warning System (EMCDDA, 2015) were analogues of fentanyl.
1 Acetylfentanyl has been reported as a cause of 14 and 40 accidental self-poisoning deaths in the US and in Sweden, respectively (Guerrieri et al., 2017; Lozier et al., 2015) . Only three novel synthetic opioids (acetylfentanyl, AH-7921 2 and U-47700 3 ) were mentioned on death certificates in England and Wales up to end-2016. AH-7921, was most frequently mentioned (5 instances, 4 in 2014, 1 in 2015), acetylfentanyl was mentioned in two deaths (2015 and 2016) , and U-47700 also in two deaths (both in 2016).
Finally, the general term 'opiate' was mentioned frequently (N ¼ 3,178) on death certificates. Methadone was the most frequently mentioned opioid (101) in these deaths. It is likely that most of these other 'opiate' deaths involved diamorphine or methadone for the simple reason that the proportion of deaths where dependent/non-dependent drug use was also mentioned on the death certificate (42%) was similar to that recorded with these drugs (diamorphine 42%, methadone 37%).
Stimulants
In assessing opioid-related deaths, toxicity is often not clearly related to dose because chronic use of such compounds leads to the development of tolerance, amongst other factors. However, although co-ingestion of respiratory depressants such as ethanol may have contributed to death, that the primary cause of death has been opioid-related is usually clear. In contrast, the toxicity of central nervous system stimulant drugs such as cocaine and amfetamines is not clearly related to dose per se. The terminal event may be serotonin syndrome or malignant hyperthermia, for example, which cannot be diagnosed from post-mortem observations alone. Hence, except where specific pathological (2014: 88, 2015: 97, 2016: 100) . Note that 396, 70, 11, and six deaths involved two, three, four, and five stimulants, respectively. However, a complication is that some drugs, for example amfetamine, are metabolites of others, metamfetamine in this example, and thus simply counting the compounds mentioned on death certificates is to an extent misleading.
The fall in MDMA-related deaths in 2009-2011 may have been related to substitution of MDMA by benzylpiperazine (BZP) in 'ecstasy' tablets (Forensic Science Service, 2010) . BZP has about 10% of the potency of D-amfetamine as a stimulant and also shows similar pharmacological effects to MDMA (Baumann et al., 2005) .
Cocaine-related deaths (3,342, 34% alone, with or without alcohol) peaked in 2008 (235) and fell to 112 in 2011, before increasing to 371 in 2016. Death rates per million population show a similar trend ( Figure 6 ). As regards co-mentioned compounds, diamorphine/ morphine was mentioned in 1,336 deaths (40%), methadone in 447 (13%), and diazepam in 246 (7.3%). Overall, 1587 (48%) of cocaine-related deaths also had heroin and/or methadone recorded on the death certificate. Amfetamine and MDMA were mentioned in 119 (3.6%) and 146 (4.3%) of cocaine-related deaths, respectively. Deaths from stimulants other than cocaine showed a similar annual picture to those of cocaine itself except that cocaine-related deaths in males rose 2001-2008, probably simply reflecting co-exposure to heroin (Table 4, Figure 6 ).
Most cocaine-and other stimulant-related deaths were of males (84% and 65%, respectively), with a median (range) age of 34 (15-86) and 31 (10-76) years, respectively. The male:female ratio of MDA/ MDEA/MDMA-related deaths, for example, remained Table 5 ).
relatively constant by year with no evident trend (median 4.2, range 0.0-19.0), 1993-2016. When all stimulant-related deaths (i.e. all those involving cocaine, MDA, MDEA, MDMA, amfetamine/metamfetamine, and other stimulants (Table 5) ), are studied by year, as with diamorphine/morphine and methadone deaths there was again a trend to older age at death (Figure 7) . However, whereas the proportion of methadone mentioned in these deaths remained relatively constant over the period studied (median 11, range 6-26%), the proportion of diamorphine/morphine mentions has increased (1993: 10%, 2016: 34%) . It is likely therefore that the recent increase in cocaine-related deaths especially and the trend to older age at death simply reflects co-exposure to opioids, notably heroin.
There were relatively few mentions of 'novel stimulants' on death certificates, and such mentions largely date from 2012 onwards ( (Gyarmathy et al., 2017; Hope et al., 2016) and could be associated with increased risk as compared to oral usage.
Although PMA/PMMA have been abused for many years, and a number of deaths have been attributed to their use (Kraner et al., 2001) , these compounds only featured in two deaths (2001, 2011) within England and Wales up until 2012, after which they were recorded in 20, 29, and 24 deaths in 2012, 2013, and 2014, respectively. In 2015, PMA/PMMA-related deaths declined to 10, and to three in 2016. The UK press reported a number of deaths that have been attributed to pills being sold as MDMA, but actually containing PMA/ PMMA (Nutt, 2015) . With this in mind, of the 88 PMA/PMMA-related deaths, 20% also had MDMA recorded on the death certificate and 15% had amfetamine mentioned. In the UK, methylphenidate is licensed for the treatment of attention deficit hyperactivity disorder, but is also prescribed off-licence for the treatment of narcolepsy. However, there are concerns over the abuse potential of methylphenidate, as when taken intranasally similar effects to those of cocaine can be achieved (Frauger et al., 2016; Morton and Stockton, 2000) . Despite this concern, there were only nine deaths (2 methylphenidate alone or with alcohol) where methylphenidate was recorded on the death certificate, and no trend was evident (1993, 1997, 2000, 2005, 2011, 2013, 2016 : 1 death record per annum, 2015: 2 deaths). The methylphenidate analogue ethylphenidate, which is also a minor metabolite of methylphenidate when coingested with ethanol, was never the great problem in England and Wales (5 deaths registered, all with other drugs with or without ethanol, see Maskell et al., 2016) that it became in Scotland, where it was largely abused by injection (Lafferty et al., 2016; Parks et al., 2015) .
Hypnosedatives
Benzodiazepines were involved in 6,383 deaths. Annual deaths declined from 278 (1993) to 177 (2006), but have since steadily increased (406 in 2016). Diazepam was involved in 53%, temazepam in 26%, and nitrazepam in 3% of all benzodiazepine-related deaths, and few were alone, with or without alcohol (15%). This is in keeping with the relatively low acute toxicity of these compounds (Buckley and McManus, 2004) . Despite the concern over the abuse of benzodiazepines (Kapil et al., 2014a) , only 25% of benzodiazepine-related deaths had dependent/non-dependent drug use mentioned on the death certificate, and of these, 55% also had heroin/ morphine mentioned. Novel or 'designer' benzodiazepines were recorded infrequently on death certificates within England and Wales. Mentions of etizolam (13) Within the UK phenazepam is not licensed, but it is prescribed in Russia, and is widely available for purchase from the internet. Mentions of phenazepam (22) date from 2011. Etizolam is also not licensed in the UK but is prescribed in Italy, Japan and India.
Barbiturates have been mentioned in 674 poisoning deaths in England and Wales, and having decreased from 42 (1993) to eight (2007) , mentions have since increased to 44 (2016) . Heroin has been traditionally adulterated with phenobarbitone, however only 19 diamorphine/morphine-related deaths have involved barbiturates, and of these, phenobarbitone was mentioned in one instance. Dependent/non-dependent drug use was only mentioned in some 2% of all barbiturate-related deaths. Internet purchase of pentobarbitone, for example, with suicide in mind are likely a factor here.
Deaths involving zopiclone (1, 013) , increased from nine (1994) to 985 in 2016. Most (77%), involved other drugs (with, or without alcohol), predominantly diamorphine/morphine (131), diazepam (115), and methadone (101). Few (6%) have dependent/non-dependent drug use mentioned on the death certificate. Zolpidem, and zaleplon feature relatively infrequently on death certificates (132 and 2 deaths, respectively).
c-Hydroxybutrate (GHB) or c-butyrolactone (GBL) have featured in 215 deaths and annual deaths were some three per year (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) , but increased from nine (2007) to 30 (2016) .
Ketamine
The misuse of ketamine is widespread and the occurrence of 'ketamine bladder' is well known (Myers et al., 2016) , but the number of deaths as a direct result of ketamine use alone were relatively small (117, 40 alone with or without alcohol, 1993-2016) . There are a few reports of fatal accidents where users put themselves at risk due to loss of consciousness while undertaking activities, such as taking a bath or going for a walk (O'Kelly, 2011).
Pregabalin, gabapentin and baclofen
Pregabalin and gabapentin are analogues of caminobutyric acid (GABA) and are prescribed as anticonvulsants and for treating neuropathic pain. Pregabalin-related deaths (285) have increased from four (2012) to 111 (2016) . Almost all (95%) involved other drugs (with or without alcohol), predominantly diamorphine/morphine (126), methadone (108), and diazepam (103). Deaths involving gabapentin (166) have shown a similar trend, having increased from four (2011), to 59 (2016) . Again, almost all (93%), involved other drugs (with, or without alcohol), predominantly diamorphine/morphine (57), diazepam (37), and methadone (28). The combination of gabapentin and pregabalin was mentioned in nine deaths only.
There has been increasing concern over the abuse potential of these compounds (Loftus and Wright, 2014; Piskorska et al., 2013 , Schifano, 2014 , in particular by those individuals with a history of opiate/opioid use (Bastiaens et al., 2016; Grosshans et al., 2013 , McNamara et al., 2015 . It has been suggested that the use of pregabalin/gabapentin with opiates/opioids (in particular heroin) has the potential to increase the risk of death by either the reversal of tolerance to the opioid, or an additive effect leading to respiratory depression. In acute experiments in mice, the respiratory depression caused by a high dose of pregabalin adds to that produced by either methadone, or fentanyl (Hill and Henderson, personal communication, 2017) , a similar additive effect on respiratory depression to that of morphine (Lyndon et al., 2017) . In chronic experiments, a single low dose of pregabalin failed to reverse methadone induced tolerance, whereas it reversed morphine-induced tolerance. This is consistent with the hypothesis that morphine and methadone induce tolerance by different mechanisms (Hill and Henderson, personal communication, 2017) .
The presence of either pregabalin, or gabapentin in diamorphine/morphine-related deaths dates primarily from 2012 and 2013 onwards, which coincides with the marked year-on-year increase in all diamorphine/ morphine related deaths (Figure 1) . Furthermore, over half (58%) of diamorphine/morphine-related deaths involving pregabalin or gabapentin are aged >39 years (30-39 years: 33%, < 30 years: 9%). Similar trends are evident when the involvement of pregabalin or gabapentin in methadone-related deaths are investigated. With this in mind, in January 2016 the ACMD recommended that both pregabalin and gabapentin should be controlled as Class C substances under the Misuse of Drugs Act 1971, and made Schedule 3 compounds under the Misuse of Drugs Regulations 2001 (ACMD, 2016) . However, despite this concern, dependent/non-dependent drug use was only mentioned in 6% and 9% of gabapentin-and pregabalin-related deaths, respectively.
It has been reported that baclofen, also an analogue of GABA, prescribed as an anticonvulsant, in the treatment of neuropathic pain and withdrawal from GHB dependence, has the potential to be misused (Kapil et al., 2014b) . However, baclofen is very toxic and is thus hardly if ever misused. It was mentioned in 20 deaths (30% alone with or without alcohol) in the period studied, almost all (85%) of which were intentional self-poisonings.
Other recreational drugs/compounds
Volatile substances
There were 676 deaths 1993-2016 where volatile substances were recorded on the death certificate, or the underlying cause was recorded as volatile substance abuse (solvent abuse) in England and Wales. For the period 1993-2009 annual numbers of such deaths were approximately 50% of those recorded for the UK as a whole (Ghodse et al., 2012) .
Annual numbers of deaths remained relatively stable from 1993 to 2002 (median 44, range 27-46), after which they steadily declined (15 in 2016). Most (80%) deaths were of males. VSA-related deaths were predominantly (84%) alone without other drugs or alcohol. Where another drug was mentioned, methadone (37), heroin/morphine (23), and cocaine (11) were most frequent. Almost all (86%) had drug abuse recorded on the death certificate.
Nitrous oxide ('laughing gas') is widely abused (Kaar et al., 2016) . Nitrous oxide was mentioned in 30 deaths. Almost all (90%) such nitrous oxide-related deaths were in males, and 90% (27) of deaths were alone without other drugs or alcohol. Most (70%) were accidental poisonings, and drug abuse was mentioned on only one death certificate.
Alkyl nitrites 'poppers' are exempt from the Psychoactive Substances Act (2016). However, there have been 28 deaths where alkyl nitrites were mentioned. Most of these deaths were of males (25), and in 17, nitrites alone (with or without alcohol) were mentioned on the death certificate. These may well have been ingestions of liquid. Only six of these deaths had drug abuse mentioned on the death certificate.
Cannabinoids
Despite cannabis being widely abused it was mentioned in less than 1% (362) of all drug-related deaths (using the ONS Standard Definition), and of these 46% had drug-abuse recorded on the death certificate. Deaths involving cannabis have remained relatively constant over the period studied, with no trend evident (median 14, range 7-28, per annum). Traditionally, cannabis has been viewed as possessing minimal acute toxicity. In accord with this view, only 34 of the cannabis-related deaths were recorded as cannabis alone or with alcohol (22 alone, without other drugs, or alcohol). Of these 34 cannabis-related deaths, 18 had the underlying cause of death recorded as accidental poisoning by exposure to cannabis. However, many had other co-morbidities mentioned on the death certificate (e.g. pulmonary oedema, chronic heart disease) that would explain the death as opposed to acute cannabis toxicity.
Be this as it may, the increase in the potency of cannabis and an evolution in the ratio between the two primary components, Á9-tetrahydrocannabinol (Á9-THC) and cannabidiol (toward a higher proportion of Á9-THC) is a cause for concern (Lafaye et al., 2017) , In recent years, there has also been a significant increase in the availability of synthetic cannabinoid receptor agonists, sometimes unhelpfully referred to by the name 'spice', which were not controlled under legislation (Gurney et al., 2014) . However, these compounds are now largely controlled in England and Wales either under modifications to the Misuse of Drugs Act 1971, or by the Psychoactive Substances Act (2016). Although some synthetic cannabinoids appear to have relatively low acute toxicity, the adverse effects recorded with others include nausea and vomiting, shortness of breath, depressed respiration, hypertension, tachycardia, chest pain, muscle twitches, acute renal failure, anxiety, agitation, psychosis, suicidal ideation and cognitive impairment (Castaneto et al., 2014; Lafaye et al., 2017) . In England and Wales there were 37 deaths (22 alone with or without alcohol) up to end-2016 where synthetic cannabinoids were mentioned on the death certificate. Such deaths largely date from 2014 (1 death in 2012), and increased from two (2014) to 26 (2016) .
The synthetic cannabinoid, N-[(2S)-1-amino-3-methyl-1-oxo-2-butanyl]-1-(cyclohexylmethyl)-1H-inda zole-3-carboxamide (AB-CHMINACA), was mentioned in one death (2015, with other drugs), and methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate (MDMB-CHMICA), was mentioned in three deaths (1 in 2015, 2 in 2016, all with other drugs) . N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-AKB-48) was mentioned in three deaths (2014, 2015, 2016) , all with other drugs mentioned, 8-quinolinyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22) was mentioned in three deaths (1 in 2015, 2 in 2016) , two of which were with other drugs, and N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-D-valine methyl ester (5F-ADB) was mentioned in three deaths (2016, 1 with other drugs). The generic term 'synthetic cannabinoid' was mentioned in 26 instances (15 alone without alcohol or other drugs mentioned), and in no instance was the specific cannabinoid recorded. Finally, the term 'cannabinoid', which may refer either to synthetic cannabinoids, or simply to cannabis itself was mentioned in 15 instances.
Likewise, annual deaths involving MDA/MDEA/ MDMA have also increased to the highest recorded number per annum (65 in 2016), although 51% of these involved other drugs and/or ethanol. The numbers of amfetamine/metamfetamine-related deaths, although having stayed relatively stable, have also increased in recent years to the highest recorded number (100) in 2016.
Although the cause of the recent increases in cocaine/MDMA/amfetamine/metamfetamine-related deaths is not clear, an increase in the potency of the substances available on the street, such as high dose 'ecstasy' tablets and high purity 'crystal' MDMA, together with a reduction in the recreational use of NPS and a return to traditional stimulants, perhaps in response to the Psychoactive Substances Act (2016), may be contributory factors (EMCDDA, 2016; Laurance, 2010) . Arguments against an increase in street purity being a factor in the recent increase in stimulant-related deaths are that (i) the toxicity of compounds such as cocaine and MDMA is not clearly related to dose (see above), (ii) crystal/powder MDMA remained available throughout the period under study and was often sold in 1 gram wraps of c. 80% purity (Forensic Science Service, 2009), and (iii) that the proportions of such deaths either alone, or with alcohol has shown no marked change over the years (Table 4) . It thus seems likely that increased availability of MDMA in the form of 'ecstasy' rather than either purity, or dose is responsible for the increased mortality apparent with this drug.
Conclusions
Illicit diamorphine (heroin) and methadone continue to be the principal drugs of abuse involved in fatal poisonings in England and Wales. It is notable that the increase in such deaths in recent years has been accompanied by an increase in deaths (i) amongst older users, perhaps influenced by an increased co-morbidity with increasing age, (ii) involving diamorphine/morphine as well as methadone (from some 10% of methadonerelated deaths 1993-1995 to 38% in 2016) , and (iii) involving gabapentin/pregabalin. As to deaths involving stimulants, annual numbers of stimulant-related deaths have increased steadily over the period studied, reaching 532, the highest figure recorded, in 2016. Moreover, there was again a trend to an increasing proportion of deaths in older users with time. Deaths involving cocaine and MDMA fell in the period 2009-2013, but have since rebounded to pre-2009 levels. The recent increase in cocaine-related deaths has been primarily in deaths that were also associated with heroin. The impact of the plethora of NPS that have appeared in recent years on fatal poisoning data may have been mitigated by legislation, with some users switching back to cocaine and MDMA. However, the threat posed by synthetic cannabinoids and opioids such as carfentanil and other fentanyl analogues especially is very real and, as with use of illicit drugs in general, has implications in other areas such as road safety.
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